Healthtech Startups
18,423 companies tagged Healthtech, with their investors and founders.
Crescendo Biologics develops novel immune cell-enhancing therapeutics for immuno-oncology using its patent-protected Humabody VH platform, a fully human domain technology clinically validated in oncology and immunology. The company collaborates with major pharmaceutical partners including BioNTech and Takeda on drug discovery and development.
6 investors
Crown Bioscience is a contract research organization based in California providing discovery, preclinical, and translational platforms and services for oncology and immuno-oncology drug development. The company serves pharmaceutical and biotech companies seeking to advance and de-risk their drug development programs.
6 investors
Cytospire Therapeutics develops multispecific antibodies and next-generation γδ T cell engagers designed to direct innate and adaptive immune effector cells as an alternative to CD3-based engagers. The company is building a portfolio of immune cell engagers aimed at cancer therapies.
6 investors
Dandelion Health develops clinical AI applications by combining healthcare domain expertise with machine learning research to advance AI adoption in healthcare.
6 investors
Dash Bio is a contract research organization (CRO) offering bioanalysis services with a technology-based, automated approach, delivering sample analysis results in days. It provides method development and validation, ELISA/MSD, LC-MS, and qPCR assays across preclinical to late-stage clinical studies for pharmaceutical and biotech companies.
6 investors
Dawaai is a licensed online pharmacy and healthcare group that procures medicines directly from manufacturers and distributors and delivers them to patients' doorsteps, including a two-hour "Fast" delivery service. It operates in Pakistan, serving retail pharmacy customers with pharmacist-handled medicine ordering and delivery.
6 investors
6 investors
DEM BioPharma is a biotechnology company developing cancer therapies by targeting the immune system, drawing on genetic and immuno-oncology research. The company applies discovery approaches based on academic work in genetics and cancer biology.
6 investors
Dialogue provides an integrated digital health platform for employees that combines virtual care, mental health services, and wellness programs in a single application. The platform serves Canadian organizations seeking to improve employee health outcomes and reduce absenteeism through centralized, coordinated healthcare access.
6 investors
Digbi Health offers a "food-as-medicine" precision care program that uses gut microbiome, genetic, and blood-marker testing to treat obesity, cardiometabolic, diabetes, and GI conditions. It combines at-home test kits, connected devices, GLP-1 medication access, and health coaching through a mobile app, and is sold to employers and health plans.
6 investors
Digitail offers a veterinary practice management system with integrated VoIP capabilities that automatically link calls to patient records and provide AI-powered transcription, summaries, and sentiment analysis. The platform consolidates phone communications, call logs, and clinical documentation in a single interface for veterinary clinics.
6 investors
Disc Medicine is a biopharmaceutical company developing therapies from discovery through clinical development for patients in need. It is led by a team of scientists and industry veterans across chemistry, clinical development, and medical affairs.
6 investors
DispatchHealth delivers in-home medical care and house call services, offering patients an alternative to emergency rooms and urgent care facilities for acute medical conditions.
6 investors
Doccla provides a remote patient monitoring service that connects medical devices and EHR systems to keep patients monitored at home, combining device logistics, project management and a CQC-registered clinical team of nurses, GPs and paramedics. It serves healthcare providers such as NHS trusts and hospitals to extend virtual care capacity and reduce the cost of care.
6 investors
doctorly offers a cloud-based practice management system (PVS) for medical practices, supporting features like KV quarterly billing, eRezept and eAU, patient record management, and device integration via GDT. The software runs across Windows, Apple, Android, and Linux devices and targets doctors and medical staff in Germany.
6 investors
Eargo was a hearing aid company that provided high-quality hearing aids and related care services. The company is currently winding down its US operations.
6 investors
Elemental Machines provides an IoT platform combining hardware, software, and data science to monitor lab and manufacturing equipment, environments, and workflows in real time. It serves R&D, manufacturing, academia, and government science operations with continuous monitoring, contextual alerts, and GxP/GMP/GLP compliance support.
6 investors
Elephant provides digital health infrastructure for public healthcare systems in low- and middle-income countries, offering an offline-capable EHR (ElephantOS), clinical guidance tools (Elephant Nudge), and an AI-driven platform to integrate third-party healthcare tools into clinical workflows.
6 investors
Empirical is a heart health company that uses comprehensive lab testing, AI-powered risk modeling, and evidence-based interventions to prevent cardiovascular disease. It serves consumers seeking proactive heart disease prevention through personalized, affordable care enabled by value-based care models and machine learning.
6 investors
Empo Health develops in-home health monitoring devices for diabetic patients and healthcare providers to improve care outcomes. The company serves diabetes management in the digital health space.
6 investors
Endogenex is a clinical-stage medical device company developing the pulsENDO system, which applies non-thermal pulsed electric field to reset the body's metabolic signaling and improve function in people with type 2 diabetes. Developed in partnership with Mayo Clinic, the therapy aims to help patients manage blood glucose levels and slow disease progression.
6 investors
Enrichly is a digital platform for pediatric behavioral health that combines gamified engagement with evidence-based interventions to strengthen self-esteem and emotional wellness in children and adolescents. It serves clinicians, therapists, counselors, parents, and schools with a closed-loop system that tracks progress and delivers data-driven insights.
6 investors
Entrada Therapeutics is a biotech company developing intracellular therapeutics based on its proprietary EEV Platform, aimed at reaching previously inaccessible or undruggable disease-causing targets inside cells. Its pipeline spans discovery to clinical-stage treatments for retinal, neuromuscular, and metabolic diseases, including Duchenne muscular dystrophy.
6 investors
Ergatta manufactures smart rowing machines with interactive coaching, gamified workouts, and scenic content. The company serves fitness enthusiasts seeking home workout equipment combining hardware with digital training features.
6 investors















